Unia Europejska -
islandzki -
EMA (European Medicines Agency)
ultifend nd ibd
ceva-phylaxia veterinary biologicals co. ltd - turkey herpes virus, strain rhvt/nd/ibd, expressing the fusion protein of newcastle disease virus and the vp2 protein of infectious bursal disease virus, live recombinant - Ónæmissjúkdómar fyrir fugla - embryonated chicken eggs; chicken - for the active immunisation of one-day-old chicks or 18-day-old chicken embryonated eggs to reduce mortality, clinical signs and lesions caused by newcastle disease virus (ndv) and to reduce virus shedding; to reduce mortality, clinical signs and bursa lesions caused by very virulent infectious bursal disease virus (ibdv); to reduce mortality, clinical signs and lesions caused by classical marek’s disease virus (mdv).
Islandia -
islandzki -
LYFJASTOFNUN (Icelandic Medicines Agency)
nebido stungulyf, lausn 1000 mg/ 4 ml
grünenthal gmbh* - testosterone - stungulyf, lausn - 1000 mg/ 4 ml
Islandia -
islandzki -
LYFJASTOFNUN (Icelandic Medicines Agency)
genestran vet stungulyf, lausn 75 míkróg/ml
animedica gmbh* - cloprostenolum natríum - stungulyf, lausn - 75 míkróg/ml
Islandia -
islandzki -
LYFJASTOFNUN (Icelandic Medicines Agency)
ivomec vet. stungulyf, lausn 10 mg/ml
boehringer ingelheim animal health france scs - ivermectinum inn - stungulyf, lausn - 10 mg/ml
Islandia -
islandzki -
LYFJASTOFNUN (Icelandic Medicines Agency)
penethaone vet (penethamate) stungulyfsstofn og leysir, dreifa 236,3 mg/ml
divasa-farmavic s.a. - penethamate hydriodide - stungulyfsstofn og leysir, dreifa - 236,3 mg/ml
Islandia -
islandzki -
LYFJASTOFNUN (Icelandic Medicines Agency)
marcain spinal stungulyf, lausn 5 mg/ml
aspen pharma trading limited - bupivacainum hýdróklóríð - stungulyf, lausn - 5 mg/ml
Islandia -
islandzki -
LYFJASTOFNUN (Icelandic Medicines Agency)
marcain spinal tung stungulyf, lausn 5 mg/ml
aspen pharma trading limited - bupivacainum hýdróklóríð - stungulyf, lausn - 5 mg/ml
Islandia -
islandzki -
LYFJASTOFNUN (Icelandic Medicines Agency)
varilrix stungulyfsstofn og leysir, lausn 2.000 pfu bóluefni
glaxosmithkline pharma a/s - varicella-zoster virus - stungulyfsstofn og leysir, lausn - 2.000 pfu bóluefni
Unia Europejska -
islandzki -
EMA (European Medicines Agency)
advate
takeda manufacturing austria ag - octocog alfa - hemophilia a - antihemorrhagics - meðferð og fyrirbyggjandi blæðingar hjá sjúklingum með dreyrasýki a (meðfæddan þáttur viii-skortur). advate inniheldur ekki von willebrand þáttur í ly árangri magni og er því ekki fram í von willebrand sjúkdómur.
Unia Europejska -
islandzki -
EMA (European Medicines Agency)
rixubis
baxalta innovations gmbh - nonacog gamma - hemophilia b - antihemorrhagics - meðferð og fyrirbyggja blæðingar í sjúklinga með dreyrasýki b (meðfædda þáttur laga skort).